Caci International Inc
$18.54B- Market cap
- $13.78B
- Debt
- +$4.95B
- Cash
- −$191.76M
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: CACI stock price at premium vs CI $623.61 current versus $307.74 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CI's multiple
Implied fair value · at CACI's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CACI FY 2026 (ended Jun 30, 2026) · CI FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Capital structure 70% equity / 30% debt · EV / Revenue 0.35x · EV / EBITDA 8.96x
CI carries the larger enterprise value at $97.38B against $18.54B; CI trades on the lower EV / Revenue multiple (0.35x vs 1.94x); CI on the lower EV / EBITDA (8.96x vs 17.07x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CACI INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
The Cigna Group · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.11x
0.75x
Net debt / EBITDA
Leverage against operating earnings
4.38x
2.09x
Cash and equivalents
Liquid reserves on the balance sheet
$191.76M
$8.73B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Science Applications International Corp
CACI vs SAIC
KBR, INC.
CACI vs KBR
Booz Allen Hamilton Holding Corp
CACI vs BAH
Leidos Holdings, Inc.
CACI vs LDOS
JACOBS SOLUTIONS INC.
CACI vs J
UNITEDHEALTH GROUP INC
CACI vs UNH
CVS HEALTH Corp
CACI vs CVS
HUMANA INC
CACI vs HUM
CENTENE CORP
CACI vs CNC
WEST PHARMACEUTICAL SERVICES INC
CACI vs WST
BAXTER INTERNATIONAL INC
CACI vs BAX
$4.95B
$31.46B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.